Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000123442 | SCV000166779 | benign | not specified | 2013-10-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Illumina Laboratory Services, |
RCV000332395 | SCV000482752 | likely benign | Sideroblastic Anemia and Ataxia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000676902 | SCV001025160 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001285826 | SCV001472321 | benign | X-linked sideroblastic anemia with ataxia | 2020-12-05 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676902 | SCV000802717 | benign | not provided | 2016-02-25 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003905184 | SCV004729359 | benign | ABCB7-related disorder | 2019-09-10 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |